HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES CHIMERIC FOR THE ENVELOPE V3 DOMAIN DIFFER IN SYNCYTIUM FORMATION AND REPLICATION CAPACITY

被引:271
作者
DEJONG, JJ
GOUDSMIT, J
KEULEN, W
KLAVER, B
KRONE, W
TERSMETTE, M
DERONDE, A
机构
[1] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,HUMAN RETROVIRUS LAB,1105 AZ AMSTERDAM,NETHERLANDS
[2] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,1105 AZ AMSTERDAM,NETHERLANDS
关键词
D O I
10.1128/JVI.66.2.757-765.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chimeric human immunodeficiency virus type 1 (HIV-1) molecular clones differing only in the envelope V3 region were constructed. The V3 regions were derived from two HIV-1 isolates with a non-syncytium-inducing, non-T-cell-tropic phenotype and from four HIV-1 isolates with a syncytium-inducing, T-cell-tropic phenotype. When assayed in SupT1 cells, the two chimeric viruses with a V3 region derived from the non-syncytium-inducing isolates did not induce syncytia and showed a low level of replication. The four chimeric viruses with a V3 region derived from the syncytium-inducing isolates did induce syncytia and replicated efficiently in SupT1 cells. In A3.01 cells, which do not support syncytium formation, the V3 loop affected replication similarly. Upon prolonged culture in SupT1 cells, the phenotype of a non-syncytium-inducing, low-replicating chimeric HIV-1 converted into a syncytium-inducing, high-replicating phenotype. Mutations within the usually conserved GPGR tip of the loop, which were shown to be responsible for the conversion into the syncytium-inducing, high-replicating phenotype, had occurred. In vitro mutagenesis showed that coupled changes of amino acids at both sides of the tip of the V3 loop were able to convert the viral phenotype from non-syncytium-inducing, low replicating into syncytium inducing, high replicating. Our data show that the V3 loop is involved in both syncytium forming and replicative capacity of HIV-1.
引用
收藏
页码:757 / 765
页数:9
相关论文
共 36 条
[1]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[2]   DEXTRAN SULFATE BLOCKS ANTIBODY-BINDING TO THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITHOUT INTERFERING WITH GP120-CD4 INTERACTIONS [J].
CALLAHAN, LN ;
PHELAN, M ;
MALLINSON, M ;
NORCROSS, MA .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1543-1550
[3]   A CD4 DOMAIN IMPORTANT FOR HIV-MEDIATED SYNCYTIUM FORMATION LIES OUTSIDE THE VIRUS BINDING-SITE [J].
CAMERINI, D ;
SEED, B .
CELL, 1990, 60 (05) :747-754
[4]  
CLERICI M, 1991, J IMMUNOL, V146, P2214
[5]   EFFECTS OF MUTATIONS IN HYPERCONSERVED REGIONS OF THE EXTRACELLULAR GLYCOPROTEIN OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 ON RECEPTOR-BINDING [J].
CORDONNIER, A ;
RIVIERE, Y ;
MONTAGNIER, L ;
EMERMAN, M .
JOURNAL OF VIROLOGY, 1989, 63 (10) :4464-4468
[6]   C-TERMINAL FRAGMENTS OF GP120 AND SYNTHETIC PEPTIDES FROM 5 HTLV-III STRAINS - PREVALENCE OF ANTIBODIES TO THE HTLV-III-MN ISOLATE IN INFECTED INDIVIDUALS [J].
DEVASH, Y ;
MATTHEWS, TJ ;
DRUMMOND, JE ;
JAVAHERIAN, K ;
WATERS, DJ ;
ARTHUR, LO ;
BLATTNER, WA ;
RUSCHE, JR .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (03) :307-316
[7]  
DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615
[8]   IDENTIFICATION OF THE PRINCIPAL NEUTRALIZING DETERMINANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS A FUSION DOMAIN [J].
FREED, EO ;
MYERS, DJ ;
RISSER, R .
JOURNAL OF VIROLOGY, 1991, 65 (01) :190-194
[9]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES [J].
GOUDSMIT, J ;
DEBOUCK, C ;
MELOEN, RH ;
SMIT, L ;
BAKKER, M ;
ASHER, DM ;
WOLFF, AV ;
GIBBS, CJ ;
GAJDUSEK, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4478-4482
[10]   ENVELOPE SEQUENCES OF 2 NEW UNITED-STATES HIV-1 ISOLATES [J].
GURGO, C ;
GUO, HG ;
FRANCHINI, G ;
ALDOVINI, A ;
COLLALTI, E ;
FARRELL, K ;
WONGSTAAL, F ;
GALLO, RC ;
REITZ, MS .
VIROLOGY, 1988, 164 (02) :531-536